On the road to growth!, page-26

Looking at fiftyone capital fund performance in the last financial year, it returned 22.6 percent, and looking at how they invest is interesting to say the least. Generally they are very carful in the company’s they’ve invested in, value investors with a big tick to the upside, certainly not a fund that invests in the speculative end of biotechnology companies, so the question is why have they taken such a big interest in PAR ?
After all the homework they have done on PAR and with all the meetings with management, they believe this isn’t your normal bio tech stock, for them there is to much upside with limited downside to ignore, and let’s not forget some other small funds with the same carefull type investing have also taken an interest .
PAR is becoming less of a speculation stock bye the day, and with some good news to come the current share price will look like a steel in the future. AIMHO